Detalhe da pesquisa
1.
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Leukemia
; 38(5): 963-968, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491306
2.
Turning the heterogeneous into homogeneous: studies on selectively isolated GABAergic interneuron subsets.
Int J Dev Neurosci
; 22(7): 533-43, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15465283